Annual Cash & Cash Equivalents
$40.36 M
-$10.64 M-20.86%
December 1, 2024
Summary
- As of March 13, 2025, MNOV annual cash & cash equivalents is $40.36 million, with the most recent change of -$10.64 million (-20.86%) on December 1, 2024.
- During the last 3 years, MNOV annual cash & cash equivalents has fallen by -$31.07 million (-43.50%).
- MNOV annual cash & cash equivalents is now -43.50% below its all-time high of $71.43 million, reached on December 31, 2021.
Performance
MNOV Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$40.36 M
-$1.92 M-4.54%
December 1, 2024
Summary
- As of March 13, 2025, MNOV quarterly cash and cash equivalents is $40.36 million, with the most recent change of -$1.92 million (-4.54%) on December 1, 2024.
- Over the past year, MNOV quarterly cash and cash equivalents has dropped by -$1.92 million (-4.54%).
- MNOV quarterly cash and cash equivalents is now -50.47% below its all-time high of $81.49 million, reached on March 31, 2005.
Performance
MNOV Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MNOV Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.9% | -4.5% |
| 3 y3 years | -43.5% | -23.7% |
| 5 y5 years | -36.7% | -23.7% |
MNOV Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -43.5% | +118.1% | -43.5% | +118.1% |
| 5 y | 5-year | -43.5% | +118.1% | -48.1% | +118.1% |
| alltime | all time | -43.5% | +906.4% | -50.5% | +1232.4% |
MediciNova Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $40.36 M(-20.9%) | $40.36 M(-4.5%) |
| Sep 2024 | - | $42.28 M(-4.6%) |
| Jun 2024 | - | $44.34 M(-5.9%) |
| Mar 2024 | - | $47.14 M(-7.6%) |
| Dec 2023 | $51.00 M(+175.6%) | $51.00 M(-1.0%) |
| Sep 2023 | - | $51.51 M(-2.6%) |
| Jun 2023 | - | $52.88 M(-4.3%) |
| Mar 2023 | - | $55.26 M(+198.6%) |
| Dec 2022 | $18.51 M(-74.1%) | $18.51 M(-64.8%) |
| Sep 2022 | - | $52.51 M(-19.5%) |
| Jun 2022 | - | $65.23 M(-3.6%) |
| Mar 2022 | - | $67.70 M(-5.2%) |
| Dec 2021 | $71.43 M(+19.0%) | $71.43 M(-4.8%) |
| Sep 2021 | - | $75.03 M(-3.6%) |
| Jun 2021 | - | $77.79 M(+2.0%) |
| Mar 2021 | - | $76.30 M(+27.1%) |
| Dec 2020 | $60.04 M(-5.9%) | $60.04 M(-2.6%) |
| Sep 2020 | - | $61.66 M(+2.0%) |
| Jun 2020 | - | $60.44 M(-1.5%) |
| Mar 2020 | - | $61.33 M(-3.9%) |
| Dec 2019 | $63.79 M(+2.4%) | $63.79 M(+1.5%) |
| Sep 2019 | - | $62.87 M(+1.8%) |
| Jun 2019 | - | $61.74 M(-2.3%) |
| Mar 2019 | - | $63.21 M(+1.4%) |
| Dec 2018 | $62.31 M(+122.6%) | $62.31 M(-0.2%) |
| Sep 2018 | - | $62.44 M(-2.7%) |
| Jun 2018 | - | $64.16 M(+1.9%) |
| Mar 2018 | - | $62.94 M(+124.8%) |
| Dec 2017 | $27.99 M(+16.1%) | $27.99 M(+14.1%) |
| Sep 2017 | - | $24.54 M(+7.2%) |
| Jun 2017 | - | $22.89 M(+5.8%) |
| Mar 2017 | - | $21.64 M(-10.3%) |
| Dec 2016 | $24.12 M(+9.2%) | $24.12 M(-3.4%) |
| Sep 2016 | - | $24.97 M(-6.0%) |
| Jun 2016 | - | $26.57 M(-3.8%) |
| Mar 2016 | - | $27.62 M(+25.1%) |
| Dec 2015 | $22.08 M(+89.2%) | $22.08 M(-6.5%) |
| Sep 2015 | - | $23.61 M(+175.2%) |
| Jun 2015 | - | $8.58 M(-5.4%) |
| Mar 2015 | - | $9.07 M(-22.2%) |
| Dec 2014 | $11.67 M | $11.67 M(-2.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2014 | - | $11.94 M(-11.6%) |
| Jun 2014 | - | $13.50 M(-8.7%) |
| Mar 2014 | - | $14.78 M(+120.6%) |
| Dec 2013 | $6.70 M(+67.1%) | $6.70 M(-37.1%) |
| Sep 2013 | - | $10.66 M(-11.3%) |
| Jun 2013 | - | $12.02 M(+296.7%) |
| Mar 2013 | - | $3.03 M(-24.5%) |
| Dec 2012 | $4.01 M(-73.4%) | $4.01 M(-30.2%) |
| Sep 2012 | - | $5.74 M(-20.9%) |
| Jun 2012 | - | $7.26 M(-34.0%) |
| Mar 2012 | - | $11.01 M(-27.1%) |
| Dec 2011 | $15.09 M(-46.6%) | $15.09 M(+72.8%) |
| Sep 2011 | - | $8.74 M(-26.7%) |
| Jun 2011 | - | $11.92 M(-62.0%) |
| Mar 2011 | - | $31.38 M(+11.1%) |
| Dec 2010 | $28.25 M(+46.8%) | $28.25 M(-9.3%) |
| Sep 2010 | - | $31.16 M(+22.9%) |
| Jun 2010 | - | $25.36 M(+62.6%) |
| Mar 2010 | - | $15.60 M(-18.9%) |
| Dec 2009 | $19.24 M(-0.3%) | $19.24 M(-25.0%) |
| Sep 2009 | - | $25.64 M(-10.5%) |
| Jun 2009 | - | $28.66 M(-12.6%) |
| Mar 2009 | - | $32.79 M(+69.9%) |
| Dec 2008 | $19.30 M(+2.8%) | $19.30 M(-16.4%) |
| Sep 2008 | - | $23.08 M(-17.7%) |
| Jun 2008 | - | $28.03 M(-0.3%) |
| Mar 2008 | - | $28.13 M(+49.8%) |
| Dec 2007 | $18.78 M(+125.3%) | $18.78 M(+26.4%) |
| Sep 2007 | - | $14.86 M(+17.4%) |
| Jun 2007 | - | $12.65 M(+82.2%) |
| Mar 2007 | - | $6.95 M(-16.7%) |
| Dec 2006 | $8.33 M(-77.9%) | $8.33 M(-78.2%) |
| Sep 2006 | - | $38.30 M(+154.1%) |
| Jun 2006 | - | $15.08 M(-24.1%) |
| Mar 2006 | - | $19.86 M(-47.3%) |
| Dec 2005 | $37.68 M(-2.9%) | $37.68 M(+87.4%) |
| Sep 2005 | - | $20.10 M(-28.0%) |
| Jun 2005 | - | $27.92 M(-65.7%) |
| Mar 2005 | - | $81.49 M(+110.0%) |
| Dec 2004 | $38.80 M(+815.0%) | $38.80 M(-28.3%) |
| Sep 2004 | - | $54.08 M |
| Dec 2003 | $4.24 M | - |
FAQ
- What is MediciNova annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for MediciNova?
- What is MediciNova annual cash & cash equivalents year-on-year change?
- What is MediciNova quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for MediciNova?
- What is MediciNova quarterly cash and cash equivalents year-on-year change?
What is MediciNova annual cash & cash equivalents?
The current annual cash & cash equivalents of MNOV is $40.36 M
What is the all time high annual cash & cash equivalents for MediciNova?
MediciNova all-time high annual cash & cash equivalents is $71.43 M
What is MediciNova annual cash & cash equivalents year-on-year change?
Over the past year, MNOV annual cash & cash equivalents has changed by -$10.64 M (-20.86%)
What is MediciNova quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MNOV is $40.36 M
What is the all time high quarterly cash and cash equivalents for MediciNova?
MediciNova all-time high quarterly cash and cash equivalents is $81.49 M
What is MediciNova quarterly cash and cash equivalents year-on-year change?
Over the past year, MNOV quarterly cash and cash equivalents has changed by -$1.92 M (-4.54%)